225 related articles for article (PubMed ID: 11418660)
1. The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo.
Wei Xq ; Orchardson M; Gracie JA; Leung BP; Gao Bm ; Guan H; Niedbala W; Paterson GK; McInnes IB; Liew FY
J Immunol; 2001 Jul; 167(1):277-82. PubMed ID: 11418660
[TBL] [Abstract][Full Text] [Related]
2. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha.
Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A
J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487
[TBL] [Abstract][Full Text] [Related]
3. The IL-15R alpha chain signals through association with Syk in human B cells.
Bulanova E; Budagian V; Pohl T; Krause H; Dürkop H; Paus R; Bulfone-Paus S
J Immunol; 2001 Dec; 167(11):6292-302. PubMed ID: 11714793
[TBL] [Abstract][Full Text] [Related]
4. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
[TBL] [Abstract][Full Text] [Related]
5. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
[TBL] [Abstract][Full Text] [Related]
6. Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist.
Mortier E; Bernard J; Plet A; Jacques Y
J Immunol; 2004 Aug; 173(3):1681-8. PubMed ID: 15265897
[TBL] [Abstract][Full Text] [Related]
7. Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site.
Mariner JM; Lantz V; Waldmann TA; Azimi N
J Immunol; 2001 Feb; 166(4):2602-9. PubMed ID: 11160322
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins.
Mortier E; Quéméner A; Vusio P; Lorenzen I; Boublik Y; Grötzinger J; Plet A; Jacques Y
J Biol Chem; 2006 Jan; 281(3):1612-9. PubMed ID: 16284400
[TBL] [Abstract][Full Text] [Related]
9. Soluble Interleukin IL-15Ralpha is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15.
Bulanova E; Budagian V; Duitman E; Orinska Z; Krause H; Rückert R; Reiling N; Bulfone-Paus S
J Biol Chem; 2007 May; 282(18):13167-79. PubMed ID: 17327231
[TBL] [Abstract][Full Text] [Related]
10. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17).
Budagian V; Bulanova E; Orinska Z; Ludwig A; Rose-John S; Saftig P; Borden EC; Bulfone-Paus S
J Biol Chem; 2004 Sep; 279(39):40368-75. PubMed ID: 15215246
[TBL] [Abstract][Full Text] [Related]
11. Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response.
Khan IA; Moretto M; Wei XQ; Williams M; Schwartzman JD; Liew FY
J Exp Med; 2002 Jun; 195(11):1463-70. PubMed ID: 12045244
[TBL] [Abstract][Full Text] [Related]
12. On-column refolding and characterization of soluble human interleukin-15 receptor alpha-chain produced in Escherichia coli.
Matsumoto M; Misawa S; Tsumoto K; Kumagai I; Hayashi H; Kobayashi Y
Protein Expr Purif; 2003 Sep; 31(1):64-71. PubMed ID: 12963342
[TBL] [Abstract][Full Text] [Related]
13. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.
Rubinstein MP; Kovar M; Purton JF; Cho JH; Boyman O; Surh CD; Sprent J
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9166-71. PubMed ID: 16757567
[TBL] [Abstract][Full Text] [Related]
14. The structure of the interleukin-15 alpha receptor and its implications for ligand binding.
Lorenzen I; Dingley AJ; Jacques Y; Grötzinger J
J Biol Chem; 2006 Mar; 281(10):6642-7. PubMed ID: 16377614
[TBL] [Abstract][Full Text] [Related]
15. Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer.
Chertova E; Bergamaschi C; Chertov O; Sowder R; Bear J; Roser JD; Beach RK; Lifson JD; Felber BK; Pavlakis GN
J Biol Chem; 2013 Jun; 288(25):18093-103. PubMed ID: 23649624
[TBL] [Abstract][Full Text] [Related]
16. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.
Lodolce JP; Boone DL; Chai S; Swain RE; Dassopoulos T; Trettin S; Ma A
Immunity; 1998 Nov; 9(5):669-76. PubMed ID: 9846488
[TBL] [Abstract][Full Text] [Related]
17. Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation.
Olsen SK; Ota N; Kishishita S; Kukimoto-Niino M; Murayama K; Uchiyama H; Toyama M; Terada T; Shirouzu M; Kanagawa O; Yokoyama S
J Biol Chem; 2007 Dec; 282(51):37191-204. PubMed ID: 17947230
[TBL] [Abstract][Full Text] [Related]
18. Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors.
Giron-Michel J; Giuliani M; Fogli M; Brouty-Boyé D; Ferrini S; Baychelier F; Eid P; Lebousse-Kerdilès C; Durali D; Biassoni R; Charpentier B; Vasquez A; Chouaib S; Caignard A; Moretta L; Azzarone B
Blood; 2005 Oct; 106(7):2302-10. PubMed ID: 15976182
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease.
Bouchaud G; Mortier E; Flamant M; Barbieux I; Plet A; Galmiche JP; Jacques Y; Bourreille A
Gastroenterology; 2010 Jun; 138(7):2378-87. PubMed ID: 20188102
[TBL] [Abstract][Full Text] [Related]
20. The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer.
Badoual C; Bouchaud G; Agueznay Nel H; Mortier E; Hans S; Gey A; Fernani F; Peyrard S; -Puig PL; Bruneval P; Sastre X; Plet A; Garrigue-Antar L; Quintin-Colonna F; Fridman WH; Brasnu D; Jacques Y; Tartour E
Cancer Res; 2008 May; 68(10):3907-14. PubMed ID: 18483276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
